Search

everythinglearnresearchcommunity

for

Search:↓

No effective treatment for frontal fibrosing alopecia was found, but oral 5-alpha-reductase inhibitors had the best response; for lichen planopilaris, topical corticosteroids were commonly used but had a high relapse rate.

The Lexington LaserComb helped regrow hair in mice with a condition similar to human hair loss.

Giant cells found in some male pattern baldness cases may help diagnose it and suggest hair is mistakenly seen as foreign by the body.

Alopecia Areata is an autoimmune hair loss condition, with various treatments showing mixed effectiveness and no guaranteed cure.

Blocking IL-17 can reduce skin inflammation in a mouse model of pityriasis rubra pilaris.

Folliculitis is an inflammation of hair follicles that requires proper diagnosis and treatment based on the specific cause.

A patient with Sézary syndrome showed improvement after treatment and the study suggested follicular mucinosis might indicate future lymphoma risk.

Light therapy can effectively treat vitiligo and hair loss caused by a specific medication.

The combination therapy effectively improved acne keloidalis nuchae.

New hair products are being developed to keep hair and scalp healthy for everyone.

Inflammation may be linked to hair loss, and targeting specific enzymes could help treat it.

Early diagnosis and treatment are crucial for preventing permanent hair loss in various scalp conditions, and while new treatments are promising, more research is needed to evaluate their effectiveness.

Oral zinc and Nd:YAG laser therapy effectively treated primary cicatricial alopecia in five patients.

Long hair can cause hair loss in the middle of the scalp, and cutting it shorter helps.

Trichoscopy effectively diagnoses and monitors cicatricial alopecias, reducing the need for biopsies.

A rare case of a woman having both lichen planus pigmentosus and classic lichen planopilaris at the same time.

Targeting IL-17 could help treat pattern hair loss.

Hydroxychloroquine is less effective than betamethasone oral mini pulse therapy for treating alopecia areata.

The treatment helped reduce symptoms and stabilize the hairline in most patients with Frontal Fibrosing Alopecia, but hair regrowth was limited.

A woman developed hair loss after starting a treatment with adalimumab, suggesting this medication might cause hair loss.

Hair loss is a rare but recognized symptom of pemphigus vulgaris, with patients usually regrowing hair after treatment.

The combination of cyclosporine and PUVA might help treat severe alopecia areata.

Some women with Frontal Fibrosing Alopecia also have Lichen Planopilaris, which can lead to more symptoms and affect hair outside the scalp.

The document concludes that doctors should recognize congenital triangular alopecia to avoid unnecessary treatments, as it does not respond to steroids like alopecia areata does.

Apoptosis may contribute to hair loss in androgenetic alopecia.

Lichen planopilaris can unusually affect only the face, causing pigmentation and scarring.

The document concludes that alopecia areata is an unpredictable autoimmune hair loss condition with no cure, but various treatments exist that require personalized approaches.

Early and aggressive treatment of scarring alopecia is important to prevent further hair follicle damage.

Topical anthralin helped regrow hair in mice with a condition similar to human alopecia.

Androgenetic alopecia involves genetics, hormones, and can be treated with medications or surgery.